Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.
2.

Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.

Bastiaannet E, Wobbes T, Hoekstra OS, van der Jagt EJ, Brouwers AH, Koelemij R, de Klerk JM, Oyen WJ, Meijer S, Hoekstra HJ.

J Clin Oncol. 2009 Oct 1;27(28):4774-80. doi: 10.1200/JCO.2008.20.1822. Epub 2009 Aug 31.

3.

Cervical tuberculous lymphadenitis mimicking distant lymph node metastasis on F-18 FDG PET/CT in a patient with gastric carcinoid tumor.

Kim HW, Choi BW, Won KS, Zeon SK.

Clin Nucl Med. 2009 Dec;34(12):946-7. doi: 10.1097/RLU.0b013e3181bed1bd. No abstract available.

PMID:
20139845
4.

Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma.

Singh B, Ezziddin S, Palmedo H, Reinhardt M, Strunk H, Tüting T, Biersack HJ, Ahmadzadehfar H.

Melanoma Res. 2008 Oct;18(5):346-52. doi: 10.1097/CMR.0b013e32830b363b.

PMID:
18781133
5.

[Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].

Müller-Mattheis V, Reinhardt M, Gerharz CD, Fürst G, Vosberg H, Müller-Gärtner HW, Ackermann R.

Urologe A. 1998 Nov;37(6):609-20. German.

PMID:
9887489
6.

[Diagnostic value of (18)F-fluorodeoxyglucose positron emission tomography/ computed tomography for N-and M-staging of malignant melanoma].

Gu H, Xu W, Song X, Dai D, Zhu L, Wang J.

Zhonghua Yi Xue Za Zhi. 2014 May 6;94(17):1309-12. Chinese.

PMID:
25142850
7.

[The values of MRI, CT, and PET-CT in detecting retropharyngeal lymph node metastasis of nasopharyngeal carcinoma].

Tang LL, Ma J, Chen Y, Zong JF, Sun Y, Wang Y, Wu HB, Cui NJ.

Ai Zheng. 2007 Jul;26(7):737-41. Chinese.

PMID:
17626750
8.

Retrospective interactive rigid fusion of (18)F-FDG-PET and CT. Additional diagnostic information in melanoma patients.

Römer W, Nömayr A, Greess H, Fiedler E, Platsch G, Schuler-Thurner B, Pfahlberg A, Hothorn T, Schuler G, Hornegger J, Bautz W, Kuwert T.

Nuklearmedizin. 2006;45(2):88-95.

PMID:
16547570
9.

Determination of indication for sentinel lymph node biopsy in clinical node-negative breast cancer using preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging.

Taira N, Ohsumi S, Takabatake D, Hara F, Takashima S, Aogi K, Takashima S, Inoue T, Sugata S, Nishimura R.

Jpn J Clin Oncol. 2009 Jan;39(1):16-21. doi: 10.1093/jjco/hyn120. Epub 2008 Nov 8.

10.

Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: Impact of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography.

Deron PB, Bonte KM, Vermeersch HF, Van de Wiele C.

Cancer Biother Radiopharm. 2011 Jun;26(3):331-4. doi: 10.1089/cbr.2010.0918. Epub 2011 Jun 28.

PMID:
21711095
11.

Splenic infarction mimicking a necrotizing metastasis of malignant melanoma on F-18 FDG PET/CT.

Ahmadzadehfar H, Brockmann H, Schmiedel A, Biersack HJ, Ezziddin S.

Clin Nucl Med. 2008 Aug;33(8):571-2. doi: 10.1097/RLU.0b013e31817dec28. No abstract available.

PMID:
18645383
13.

Gallbladder metastasis from malignant melanoma: diagnosis with FDG PET/CT.

Rehani B, Strohmeyer P, Jacobs M, Mantil J.

Clin Nucl Med. 2006 Dec;31(12):812-3.

PMID:
17117082
14.

Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.

Bannas P, Weber C, Adam G, Frenzel T, Derlin T, Mester J, Klutmann S.

Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):445-51. doi: 10.1016/j.ijrobp.2010.05.050. Epub 2010 Sep 9.

PMID:
20832181
15.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
16.

Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.

Yun M, Lim JS, Noh SH, Hyung WJ, Cheong JH, Bong JK, Cho A, Lee JD.

J Nucl Med. 2005 Oct;46(10):1582-8.

17.

18F-FDG PET/CT for staging of penile cancer.

Scher B, Seitz M, Reiser M, Hungerhuber E, Hahn K, Tiling R, Herzog P, Reiser M, Schneede P, Dresel S.

J Nucl Med. 2005 Sep;46(9):1460-5.

18.

PET/CT in malignant melanoma: contrast-enhanced CT versus plain low-dose CT.

Pfluger T, Melzer HI, Schneider V, La Fougere C, Coppenrath E, Berking C, Bartenstein P, Weiss M.

Eur J Nucl Med Mol Imaging. 2011 May;38(5):822-31. doi: 10.1007/s00259-010-1702-z. Epub 2011 Jan 6.

PMID:
21210112
19.

F-18 FDG PET positive hilar and mediastinal lymphadenopathy mimicking metastatic disease in a melanoma patient treated with interferon-alpha-2b.

Kalkanis D, Kalkanis A, Gomaa O, Paes FM, Sfakianakis GN.

Clin Nucl Med. 2011 Feb;36(2):154-5. doi: 10.1097/RLU.0b013e318203bea5.

PMID:
21220988
20.

Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?

Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M.

Acta Gastroenterol Belg. 2007 Oct-Dec;70(4):331-8.

PMID:
18330088
Items per page

Supplemental Content

Write to the Help Desk